SCHEDULE 13G 0002117529 XXXXXXXX LIVE Common Stock, $0.0001 par value per share 01/30/2026 0001835022 Coya Therapeutics, Inc. 22407B108 5850 San Felipe St., Suite 500 Houston TX 77057 Rule 13d-1(c) Dr. Reddy's Laboratories, Inc. NJ 2272727.00 0.00 2272727.00 0.00 2272727.00 N 9.7 CO Note to Row 11: Based upon 20,924,456 shares of Common Stock of the Issuer outstanding as of November 10, 2025, as reported in the Issuer's Quarterly Report on Form 10-Q ("Form 10-Q") filed with the Securities and Exchange Commission (the "SEC") on November 12, 2025 and 2,522,727 shares of Common Stock of the Issuer issued and outstanding as of January 29, 2026, as reported in the Issuer's Form 8-K filed with the SEC on January 30, 2026. Dr. Reddy's Laboratories SA V8 2272727.00 0.00 2272727.00 0.00 2272727.00 N 9.7 OO Note to Rows 5, 7 and 9: Represents shares directly held by Dr. Reddy's Laboratories, Inc., a wholly-owned subsidiary of Dr. Reddy's Laboratories SA. Dr. Reddy's Laboratories SA is a wholly-owned subsidiary of Dr. Reddy's Laboratories Limited. As a result, each of Dr. Reddy's Laboratories Limited and Dr. Reddy's Laboratories SA may each be deemed to beneficially own the shares held by Dr. Reddy's Laboratories Inc. Note to Row 11: Based upon 20,924,456 shares of Common Stock of the Issuer outstanding as of November 10, 2025, as reported in the Issuer's Quarterly Report on Form 10-Q filed with the SEC on November 12, 2025 and 2,522,727 shares of Common Stock of the Issuer issued and outstanding as of January 29, 2026, as reported in the Issuer's Form 8-K filed with the SEC on January 30, 2026. Dr. Reddy's Laboratories Limited K7 2272727.00 0.00 2272727.00 0.00 2272727.00 N 9.7 OO Note to Rows 5, 7 and 9: Represents shares directly held by Dr. Reddy's Laboratories, Inc., a wholly-owned subsidiary of Dr. Reddy's Laboratories SA. Dr. Reddy's Laboratories SA is a wholly-owned subsidiary of Dr. Reddy's Laboratories Limited. As a result, each of Dr. Reddy's Laboratories Limited and Dr. Reddy's Laboratories SA may each be deemed to beneficially own the shares held by Dr. Reddy's Laboratories Inc. Note to Row 11: Based upon 20,924,456 shares of Common Stock of the Issuer outstanding as of November 10, 2025, as reported in the Issuer's Quarterly Report on Form 10-Q filed with the SEC on November 12, 2025 and 2,522,727 shares of Common Stock of the Issuer issued and outstanding as of January 29, 2026, as reported in the Issuer's Form 8-K filed with the SEC on January 30, 2026. Coya Therapeutics, Inc. 5850 San Felipe St., Suite 500, Houston, TX 77057 Dr. Reddy's Laboratories, Inc. Dr. Reddy's Laboratories SA Dr. Reddy's Laboratories Limited Dr. Reddy's Laboratories, Inc. - 600 College Road East, Suite 4000, Princeton, NJ 08540 Dr. Reddy's Laboratories SA - Grosspeter Tower Grosspeteranlage 294052 Basel, Switzerland Dr. Reddy's Laboratories Limited - 8-2-337, Road No. 3, Banjara Hills Hyderabad, Telangana 500 034, India Dr. Reddy's Laboratories, Inc. - New Jersey Dr. Reddy's Laboratories SA - Switzerland Dr. Reddy's Laboratories Limited - Republic of India Y Dr. Reddy's Laboratories, Inc. is the record owner of 2,272,727 shares of Common Stock of the Issuer. Dr. Reddy's Laboratories, Inc. is a wholly-owned subsidiary of Dr. Reddy's Laboratories SA and Dr. Reddy's Laboratories SA is a wholly-own subsidiary of Dr. Reddy's Laboratories Limited. Dr. Reddy's Laboratories Limited, Dr. Reddy's Laboratories SA and Dr. Reddy's Laboratories, Inc. may be deemed to beneficially own these securities. 9.7% Dr. Reddy's Laboratories, Inc. - 2,272,727 Dr. Reddy's Laboratories SA - 2,272,727 Dr. Reddy's Laboratories Limited - 2,272,727 Dr. Reddy's Laboratories, Inc. - None Dr. Reddy's Laboratories SA - None Dr. Reddy's Laboratories Limited - None Dr. Reddy's Laboratories, Inc. - 2,272,727 Dr. Reddy's Laboratories SA - 2,272,727 Dr. Reddy's Laboratories Limited - 2,272,727 Dr. Reddy's Laboratories, Inc. - None Dr. Reddy's Laboratories SA - None Dr. Reddy's Laboratories Limited - None Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Dr. Reddy's Laboratories, Inc. /s/ Stephen Peterson 03/12/2026 Dr. Reddy's Laboratories SA /s/ Sameer Natu 03/12/2026 Dr. Reddy's Laboratories Limited /s/ K Randhir Singh 03/12/2026